June 8, 2020 / 11:17 AM / a month ago

BRIEF-Akcea Announces Approval For Reimbursement Of Tegsedi(Inotersen) In Italy

June 8 (Reuters) - Akcea Therapeutics Inc:

* AKCEA ANNOUNCES APPROVAL FOR REIMBURSEMENT OF TEGSEDI® (INOTERSEN) IN ITALY FOR TREATMENT OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below